Session Information
2011 Summer Meeting
Click here to go to the previous page
Evidence-Based Approach to the Management of Cardiometabolic Risk in Chronic Kidney Disease
Track:
Education Sessions (CE)
Program Code: 110-L01
Date: Monday, June 13, 2011
Time: 1:30 PM to 4:00 PM MST
Location:
301
PRESENTER(S):
Sarah Anderson
Dr. Joel Marrs, Pharm.D., BCPS (AQ Cardiology), CLS, Assistant Professor, University of Colorado Denver School of Pharmacy
PROGRAM CHAIR:
Dr. Joel Marrs, Pharm.D., BCPS (AQ Cardiology), CLS, Assistant Professor, University of Colorado Denver School of Pharmacy
Description
Feeling some reluctance about aggressive treatment of patients with CKD? You’re not alone. In this session you’ll connect with experts who’ll guide you in interpreting current guidelines. You’ll gain the confidence to implement initiatives leading to improved outcomes in this complex patient population.
- Describe evidence supporting use of pharmacotherapy for hypertension, dyslipidemia, and diabetes in CKD patients.
- Evaluate challenges in treating hypertension, dyslipidemia, and diabetes in CKD patients that are transitioning from inpatient to ambulatory care settings.
- Identify clinical controversies regarding the benefits of treating hypertension, dyslipidemia, and diabetes in CKD patients.
- Interpret current guideline recommendations for treating hypertension, dyslipidemia, and diabetes in CKD patients and project how new guidelines will be different.
This session is a part of:
This session is a part of: